CARPALL CD19+CD22 CAR T-cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CARPALL CD19+CD22 CAR T-cells, covering 2025-04-02 to 2025-04-02. Get the full timeline:
Most recent: Clinical Trial Update: CARPALL: Immunotherapy with CD19+CD22 CAR T-cells for CD19+ and CD22+ Acute Lymphoblastic Leukaemia [Phase 1]